Mock James M
Chief Financial Officer
Mock James M has filed 17 SEC Form 4 filings (95 transaction rows) across 1 company, with disclosures dating back to 2025. 16 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Mock James M is listed as Chief Financial Officer at Moderna, Inc. Inside the rolling window, Mock James M reported no open-market purchases and 1 open-market sale totaling $4.7M in MRNA.
Companies traded
Other insiders at MRNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mock James M made?
Mock James M has filed 17 SEC Form 4 filings (95 transaction rows) across 1 company since 2025.
Which companies does Mock James M trade?
Mock James M has filed SEC Form 4 disclosures for 1 company, including MRNA.
When was Mock James M's most recent SEC Form 4 filing?
Mock James M's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Mock James M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mock James M is listed as Chief Financial Officer.
What is Mock James M's total buy and sell value in the current window?
Inside the rolling retention window, Mock James M bought $0 and sold $4.7M based on SEC Form 4 filings.
What was Mock James M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 34,836 MRNA shares on 2026-09-10, worth $4.7M, per SEC Form 4 filings.